Clinical Research Directory
Browse clinical research sites, groups, and studies.
Perioperative Topical Nepafenac After Epiretinal Membrane Surgery
Sponsor: Ankara Yildirim Beyazıt University
Summary
This prospective comparative study evaluates whether perioperative topical nepafenac improves early anatomical and functional recovery after pars plana vitrectomy with epiretinal membrane and internal limiting membrane peeling. The study compares postoperative visual acuity, central macular thickness, and other clinical outcomes between patients treated with perioperative nepafenac and those receiving standard postoperative care.
Official title: Perioperative Topical Nepafenac Enhances Early Anatomical and Functional Recovery After Epiretinal Membrane Surgery: A Prospective Comparative Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-01-01
Completion Date
2026-01-01
Last Updated
2026-07-30
Healthy Volunteers
No
Conditions
Interventions
Nepafenac 0.1% Ophthalmic Suspension
Topical nepafenac 0.1% administered three times daily beginning one week before surgery and continued for four weeks after surgery, in addition to standard postoperative treatment.
Pars Plana Vitrectomy With Epiretinal Membrane and Internal Limiting Membrane Peeling
Standard pars plana vitrectomy with epiretinal membrane and internal limiting membrane peeling performed for epiretinal membrane.
Locations (1)
Ankara Bilkent City Hospital
Ankara, Ankara, Turkey (Türkiye)